Mariner’s Asensus Surgical, Inc. ASXC Stock Holding History

Mariner’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,085	Closed	-$6.61K	–	3039
2023 Q2	$6.61K	Sell	13,085 -7	-0.1%	-$4	﹤0.01%	2817
2023 Q1	$9K	Sell	13,092 -112	-0.8%	-$76	﹤0.01%	2760
2022 Q4	$5K	Sell	13,204 -3,716	-22%	-$1.51K	﹤0.01%	2730
2022 Q3	$8K	Buy	+16,920	New	+$8.82K	﹤0.01%	2425
2019 Q3	–	Sell	-6,202	Closed	-$110K	–	1075
2019 Q2	$110K	Buy	6,202 +646	+12%	+$14.1K	﹤0.01%	1078
2019 Q1	$172K	Hold	5,556	–	–	﹤0.01%	978
2018 Q4	$163K	Buy	5,556 +171	+3%	+$7.77K	﹤0.01%	786
2018 Q3	$406K	Hold	5,385	–	–	0.01%	597
2018 Q2	$305K	Buy	+5,385	New	+$196K	0.01%	633
2018 Q1	–	Sell	-5,385	Closed	-$135K	–	700
2017 Q4	$135K	Hold	5,385	–	–	0.01%	551
2017 Q3	$100K	Hold	5,385	–	–	﹤0.01%	495
2017 Q2	$50K	Buy	5,385 +3,847	+250%	+$36.6K	﹤0.01%	495
2017 Q1	$24K	Hold	1,538	–	–	﹤0.01%	583
2016 Q4	$26K	Hold	1,538	–	–	﹤0.01%	555
2016 Q3	$34K	Hold	1,538	–	–	﹤0.01%	669
2016 Q2	$24K	Hold	1,538	–	–	﹤0.01%	533
2016 Q1	$85K	Hold	1,538	–	–	0.01%	505
2015 Q4	$50K	Hold	1,538	–	–	﹤0.01%	450
2015 Q3	$45K	Buy	+1,538	New	+$57K	﹤0.01%	515

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mariner's ASXC Position: Q3 2023 in Review

Mariner sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 13,085 shares — an estimated $6.61K sold.

Mariner first reported a position in ASXC in Q3 2015 and held it in 19 quarters. The position peaked at $406K in Q3 2018. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

Mariner reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
Mariner sold 13,085 Asensus Surgical, Inc. shares in Q3 2023, an estimated $6.61K.
Mariner first reported a position in Asensus Surgical, Inc. in Q3 2015 and held it in 19 quarters.
Mariner's Asensus Surgical, Inc. position peaked at $406K in Q3 2018.
68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Mariner's 13F filing for Q3 2023, filed 13 Nov 2023.